Gary S. Jacob is Chairman at SYNERGY PHARMACEUTICALS, INC. (SGYP). They have made 8 open-market trades across 6 companies since 2006, most recently 2026-07-21.
CIK 0001266802
8 open-market purchases totalling $184K since 2006, never a sale. Across 8 scored buys the stock is up 6.4% at ninety days, and 0.6 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 25% | 25% | 13% |
| Avg Move | -11.9% | -5.5% | +6.4% |
| Alpha | -34.7% | -6.9% | +0.6% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OKYO | BUY | 2022-05-19 | 2022-05-19 | $4.00 | $50K | -40.8% | -35.4% | -32.1% |
| CRDF | BUY | 2021-03-23 | 2021-03-23 | $10.42 | $25K | -4.5% | -14.0% | -23.6% |
| VRPX | BUY | 2021-02-17 | 2021-02-19 | $6.79 | $24K | -12.6% | -21.4% | -36.4% |
| HEPA | BUY | 2020-12-01 | 2020-12-01 | $1.66 | $20K | +0.0% | +0.0% | +0.0% |
| CRDF | BUY | 2020-05-14 | 2020-05-18 | $1.43 | $25K | +28.0% | +38.9% | +193.3% |
| SGYP | BUY | 2017-05-26 | 2017-05-30 | $3.52 | $20K | +16.5% | +26.4% | -11.0% |
| SGYP | BUY | 2014-05-27 | 2014-05-28 | $4.18 | $17K | -28.4% | -3.9% | -3.9% |
| KAL | BUY | 2006-08-21 | 2006-08-22 | $0.84 | $4K | -53.3% | -34.9% | -34.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| TROV |
| 148,954 |
| — |
| Total | $372K |
Shares reported on the most recent Form 4, priced at the 2026-07-23 close. 1 holding could not be priced and is excluded from the total.